ACR 2025 Dives Into College’s AI Efforts
Recent ACR Data Science Institute initiatives ARCH-AI, AI Central and Assess-AI were discussed at ACR 2025.
Read moreACR Data Science Institute’s AI Central has been updated with three new Transparent-AI products and three new products to the directory.
Three new products were added to our Transparent-AI program, which is designed to increase transparency in imaging AI and help end users have better informed discussions and selection criteria when making decisions about which algorithm might be most appropriate for their local target population.
Perspectum Diagnostics Ltd. joined the Transparent-AI program with their products MRCP+, Hepatica, and LiverMultiScan.
Transparent-AI consists of voluntarily provided data elements solicited from participating imaging AI manufacturers who currently have an FDA-cleared product in the U.S. market. Manufacturers who participate in this program will receive the Transparent-AI badge on their product listing.
Our AI Central directory has also been updated with three new products. This information is pulled directly from FDA 510K documents and updated by ACR staff. With this latest update, we see newly cleared FDA products designed for pediatric x-rays, chest CTs and prostate MR images.
New products include:
EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)
Cardiac CT Function Software Application
ACR 2025 Dives Into College’s AI Efforts
Recent ACR Data Science Institute initiatives ARCH-AI, AI Central and Assess-AI were discussed at ACR 2025.
Read moreAMA CPT Panel Considers AI-Related Codes
ACR is bringing expert input to the AMA CPT Editorial Panel during ongoing listening sessions on AI-related codes.
Read moreAI Effect on Clinical Practice
The 2025 SIIM-ACR Data Science Summit brought together leaders in radiology, informatics and healthcare artificial intelligence to explore how AI is reshaping clinical practice.
Read more